BILIRUBIN REAGENT(XL BILIRUBIN )
- UID
- MFG/IVD/2022/000042_ed9f5e866a9c5bd5c7e3e23420ceebc7_87f213c2b785b08620e0e4f6b3c38df5
- Device class
- Class B
- Brand name
- LIQUIXX -M- URIC ACID
- License holder
- Transasia Bio-Medicals Limited
- Approving authority
- Solan(BBN)
- Product information
- Diagnostic reagent for quantitative in vitro determination of Bilirubin Direct in human serum and plasma
BILIRUBIN REAGENT(XL BILIRUBIN ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2022/000042_ed9f5e866a9c5bd5c7e3e23420ceebc7_87f213c2b785b08620e0e4f6b3c38df5. This device is marketed under the brand name LIQUIXX -M- URIC ACID. The license holder is Transasia Bio-Medicals Limited, and it is classified as Device Class Class B. The approving authority is Solan(BBN).
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.